Search by Drug Name or NDC
NDC 24562-0003-30 Fludeoxyglucose F18 300 mCi/mL Details
Fludeoxyglucose F18 300 mCi/mL
Fludeoxyglucose F18 is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Biomedical Research Foundation of Northwest Louisiana. The primary component is FLUDEOXYGLUCOSE F-18.
Product Information
| NDC | 24562-0003 |
|---|---|
| Product ID | 24562-003_b0279f0d-06f8-4958-b492-22ba4e9361d5 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Fludeoxyglucose F18 |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Fludeoxyglucose F-18 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | mCi/mL |
| Substance Name | FLUDEOXYGLUCOSE F-18 |
| Labeler Name | Biomedical Research Foundation of Northwest Louisiana |
| Pharmaceutical Class | Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203837 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24562-0003-30 (24562000330)
| NDC Package Code | 24562-003-30 |
|---|---|
| Billing NDC | 24562000330 |
| Package | 30 mL in 1 VIAL, GLASS (24562-003-30) |
| Marketing Start Date | 2015-05-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |